VJHemOnc is committed to improving our service to you

ASCO 2019 | Should we transplant or not in frontline therapy for MCL?

VJHemOnc is committed to improving our service to you

Tycel Phillips

Tycel Phillips, MD, of the University of Michigan, Ann Arbor, MI, discusses if we should transplant or not in frontline therapy for mantle cell lymphoma (MCL) at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter